Overview

Phase 2/3 Oxabact Study

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering urinary oxalate levels in patients with primary hyperoxaluria.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
OxThera